AltPep

AltPep

AltPep

AltPep Corporation provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Founded
2018
Raised
$23.1M
Follow us
Latest funding
$23,100,000
Venture capital (Series A) - 2021
Matrix Capital Management Alexandria Venture Investments
Team Size
1–10
Employees
$23,100,000 Venture capital (Series A)
GeekWire

Seattle biotech startup AltPep raises $23.1M to tackle Alzheimer’s and related diseases